London, July 31, 2019 (GLOBE NEWSWIRE) -- According to a new market research report “Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025”, published by Meticulous Research®, the global radiotherapy market is expected to grow at a CAGR of 5.6% from 2019 to reach $10.15 billion by 2025.
The growing awareness about the benefits of radiotherapy for cancer control and eradication, increasing incidence & prevalence of cancer, and technological advancements in the field of radiotherapy are the key factors driving steady growth of the overall radiotherapy market.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5023
According to GLOBOCAN, in 2012, about 14.1 million new cancer cases were diagnosed across the globe, which increased by ~28% to reach 18.1 million new cases in 2018. Further, these numbers are expected to rise by ~110% to 29.5 million cases by 2040. Therefore, with increase in the volume of cancer patients globally, the number of radiotherapy procedures performed is growing rapidly. Due to this increase, the number of radiotherapy equipment installations is also increasing simultaneously. For instance, according to the American Association for Cancer Research (AACR), the demand for radiotherapy procedures has increased steadily over the past decade. According to the estimates, in the U.S., 3.05 million patients received radiation therapy in 2016, which is expected to increase by ~37%, reaching 4.17 million by 2040.
The radiotherapy market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2025 - by product, procedure, technology, application, end user, and region. The study also evaluates industry competitors and analyzes the market at a regional and country level.
Based on product type, the radiotherapy devices segment is estimated to account for the largest share of the overall radiotherapy market in 2019. The large share of this segment is mainly attributed to increasing installations of radiotherapy systems, globally with the rising demand for radiotherapy procedures for cancer treatment and new product launches with advanced technologies.
Based on procedure, external beam radiotherapy segment is poised to account for the largest share of the overall radiotherapy market in 2019 and is also expected to witness the highest growth during the forecast period. The large adoption of this procedure segment is mainly attributed to better clinical outcomes, high specificity towards tumor cells, and continuous advancements in external beam radiotherapy procedures.
Based on technology, the external beam radiotherapy market is classified into IMRT, IGRT, SRT, 3DCRT, Particle Therapy, and VMAT. The particle beam therapy segment is projected to grow at the highest CAGR during the next 5-6 years, mainly due to continuous innovations in the particle beam therapy technologies, increasing availability of advanced proton therapy systems, and increasing investment in the proton therapy room across the globe.
Speak to Our Expert Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5023
Based on application, the prostate cancer segment is projected to grow at the highest CAGR during the forecast period, mainly due to rising incidence of prostate cancer and related mortality, growing diagnosis and treatment rate of the disease, and increasing awareness about the fatality and benefits of early diagnosis and treatment across the globe.
Based on end user, the hospitals segment accounted the largest share of the global market, mainly due to large volume of patient admissions in hospitals for treatment of cancer and higher affordability of hospitals for high cost medical devices.
The report also includes extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016–2019). The radiotherapy market has witnessed number of product launches and approvals in recent years. For instance, in December 2018, Elekta AB (Sweden) received approval of Elekta Unity magnetic resonance radiation therapy (MR/RT) system. Similarly, in June 2017, Varian Medical Systems, Inc. received FDA 510(k) clearance for its Halcyon system, which offers advanced treatments for prostate, breast, head & neck, and many other forms of cancer.
The radiotherapy market is highly competitive with the presence of several small and large players. The key players operating in the global radiotherapy market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C. R. Bard, Inc., Mevion Medical Systems, Inc., Hitachi, Ltd., ViewRay, Inc., Panacea Medical Technologies Pvt. Ltd., Isoray, Inc., Optivus Proton Therapy, Inc., P-Cure, Ltd., Provison Healthcare, LLC, Ion Beam Applications S.A., and Theragenics Corporation among others.
Browse key industry insights spread across 403 pages with 376 market data tables & 86 figures & charts from the report: https://www.meticulousresearch.com/product/radiotherapy-market-5023/
Scope of the Report:
Market by Procedure
- External Beam radiotherapy
- Linear Accelerator based Teletherapy
- Cobalt-60 based teletherapy
- Proton Therapy
- Internal Beam Radiotherapy
- Brachytherapy
- Systemic Radiotherapy
Market by Product
- Radiotherapy Devices
- External beam radiotherapy systems
- Conventional Linear Accelerators (LINAC)
- Conventional Cobalt-60 Teletherapy units
- Advanced Stereotactic Radiotherapy Units (Linear Accelerator/Cobalt- 60 unit)
- Cyberknife
- Gamma knife
- Tomotherapy
- Proton Therapy Systems
- Cyclotron
- Synchrotron
- Synchrocyclotron
- Internal Beam radiotherapy systems
- Brachytherapy
- Afterloaders
- Electronic Brachytherapy products
- Brachytherapy
- External beam radiotherapy systems
- Radiotherapy Consumables & Accessories
- External beam radiotherapy
- Cobalt-60 Source
- Others
- Internal Beam Radiotherapy
- Brachytherapy
- Brachytherapy Applicators
- Brachytherapy seeds
- Systemic Radiotherapy
- Iobenguane
- Samarium-153
- Rhenium-186
- Others
- Brachytherapy
- External beam radiotherapy
- Software
- Services
Market by Technology
- External Beam Radiotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-guided Radiation Therapy (IGRT)
- Stereotactic Radiation Therapy
- 3D Conformal Radiation Therapy
- Particle Therapy
- Volumetric Modulated Arc Therapy (VMAT)
- Internal Beam Radiotherapy
- Brachytherapy
- High Dose Rate Brachytherapy (HDR)
- Low Dose Rate Brachytherapy (LDR)
- Image-guided Brachytherapy (IGBT)
- Pulse Dose Rate Brachytherapy (PDR)
- Systemic Radiation Therapy
- Intravenous radiotherapy
- Oral Radiotherapy
- Brachytherapy
Market by Application
- Prostate Cancer
- Brain Tumor
- Breast Cancer
- Lung Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
Market by End user
- Hospitals
- Independent Radiotherapy Centers
- Cancer Research Institutes
Market by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- India
- Japan
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa.
Download Free Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5023
Related Reports-
Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025
https://www.meticulousresearch.com/product/interventional-oncology-market-4951/
Multimodal Imaging Market By Product (Equipment, Reagent, Software), Technology (PET-CT, SPECT-CT, PET-MRI), Application [Clinical (Oncology, Orthopedic, Cardiology), Research], End User (Hospitals, Diagnostic Centers, Academia)- Global Forecast to 2024
https://www.meticulousresearch.com/product/multimodal-imaging-market/
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.